extended-release buprenorphine (BXR)
7963
Phase 2 small_molecule on_hold
Quick answer
extended-release buprenorphine (BXR) for Opioid-use Disorder is a Phase 2 program (small_molecule) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BRIGHT MINDS BIOSCIENCES INC.
- Indication
- Opioid-use Disorder
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- on_hold